Anticancer Activity of Copper Complex of (4R)-(-)-2-Thioxo-4-thiazolidinecarboxylic Acid and 3-Rhodaninepropionic Acid on Prostate and Breast Cancer Cells by Fluorescent Microscopic Imaging

Fang Xie, Fangyu Peng

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Copper complexes with strong anticancer activity are promising new drugs for treatment of patients with metastatic cancer. Copper 8-hydroxyquinoline-2-carboxaldehyde-thiosemicarbazide (CuHQTS) and copper 8-hydroxyquinoline-2-carboxaldehyde-4,4-dimethyl-3-thiosemicarbazide (CuHQDMTS) were found to have strong anticancer activity against cisplatin-resistant neuroblastoma cells and prostate cancer cells. This study aimed to synthesize and characterize two new anticancer copper complexes, copper complex of (4R)-(−)-2-Thioxo-4-thiazolidinecarboxylic acid (CuTTDC), and copper complex of 3-Rhodaninepropionic acid-copper complex (CuRDPA). Cell growth inhibition and cytotoxicity of CuTTDC and CuRDPA on prostate and breast cancer cells were evaluated with Cell Counting Kits-8 (CCK8) assay and fluorescent microscopic imaging respectively. Strong anticancer activity of CuTTDC and CuRDPA was demonstrated by growth inhibition and cytotoxicity of prostate and breast cancer cells treated with these two copper complexes, supporting further investigation of potential use of these two new anticancer complexes for treatment of prostate and breast cancer metastasis.

Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalJournal of Fluorescence
DOIs
StateAccepted/In press - Sep 9 2017

Fingerprint

Copper
Prostatic Neoplasms
cancer
Cells
Breast Neoplasms
Imaging techniques
Acids
Oxyquinoline
Cytotoxicity
2-thioxo-4-thiazolidinecarboxylic acid
Cell growth
drug
Growth
Neuroblastoma
Cisplatin
Assays
Neoplasm Metastasis
Therapeutics
Pharmaceutical Preparations
Neoplasms

Keywords

  • (4R)-(-)-2-Thioxo-4-thiazolidinecarboxylic acid
  • 3-Rhodaninepropionic acid
  • Anticancer copper complex
  • Breast cancer
  • Fluorescent microscopic imaging
  • Green fluorescence protein
  • Prostate cancer

ASJC Scopus subject areas

  • Biochemistry
  • Spectroscopy
  • Clinical Biochemistry

Cite this

@article{a5235c828e134a3daeb19342a2dfe5ea,
title = "Anticancer Activity of Copper Complex of (4R)-(-)-2-Thioxo-4-thiazolidinecarboxylic Acid and 3-Rhodaninepropionic Acid on Prostate and Breast Cancer Cells by Fluorescent Microscopic Imaging",
abstract = "Copper complexes with strong anticancer activity are promising new drugs for treatment of patients with metastatic cancer. Copper 8-hydroxyquinoline-2-carboxaldehyde-thiosemicarbazide (CuHQTS) and copper 8-hydroxyquinoline-2-carboxaldehyde-4,4-dimethyl-3-thiosemicarbazide (CuHQDMTS) were found to have strong anticancer activity against cisplatin-resistant neuroblastoma cells and prostate cancer cells. This study aimed to synthesize and characterize two new anticancer copper complexes, copper complex of (4R)-(−)-2-Thioxo-4-thiazolidinecarboxylic acid (CuTTDC), and copper complex of 3-Rhodaninepropionic acid-copper complex (CuRDPA). Cell growth inhibition and cytotoxicity of CuTTDC and CuRDPA on prostate and breast cancer cells were evaluated with Cell Counting Kits-8 (CCK8) assay and fluorescent microscopic imaging respectively. Strong anticancer activity of CuTTDC and CuRDPA was demonstrated by growth inhibition and cytotoxicity of prostate and breast cancer cells treated with these two copper complexes, supporting further investigation of potential use of these two new anticancer complexes for treatment of prostate and breast cancer metastasis.",
keywords = "(4R)-(-)-2-Thioxo-4-thiazolidinecarboxylic acid, 3-Rhodaninepropionic acid, Anticancer copper complex, Breast cancer, Fluorescent microscopic imaging, Green fluorescence protein, Prostate cancer",
author = "Fang Xie and Fangyu Peng",
year = "2017",
month = "9",
day = "9",
doi = "10.1007/s10895-017-2177-0",
language = "English (US)",
pages = "1--8",
journal = "Journal of Fluorescence",
issn = "1053-0509",
publisher = "Springer New York",

}

TY - JOUR

T1 - Anticancer Activity of Copper Complex of (4R)-(-)-2-Thioxo-4-thiazolidinecarboxylic Acid and 3-Rhodaninepropionic Acid on Prostate and Breast Cancer Cells by Fluorescent Microscopic Imaging

AU - Xie, Fang

AU - Peng, Fangyu

PY - 2017/9/9

Y1 - 2017/9/9

N2 - Copper complexes with strong anticancer activity are promising new drugs for treatment of patients with metastatic cancer. Copper 8-hydroxyquinoline-2-carboxaldehyde-thiosemicarbazide (CuHQTS) and copper 8-hydroxyquinoline-2-carboxaldehyde-4,4-dimethyl-3-thiosemicarbazide (CuHQDMTS) were found to have strong anticancer activity against cisplatin-resistant neuroblastoma cells and prostate cancer cells. This study aimed to synthesize and characterize two new anticancer copper complexes, copper complex of (4R)-(−)-2-Thioxo-4-thiazolidinecarboxylic acid (CuTTDC), and copper complex of 3-Rhodaninepropionic acid-copper complex (CuRDPA). Cell growth inhibition and cytotoxicity of CuTTDC and CuRDPA on prostate and breast cancer cells were evaluated with Cell Counting Kits-8 (CCK8) assay and fluorescent microscopic imaging respectively. Strong anticancer activity of CuTTDC and CuRDPA was demonstrated by growth inhibition and cytotoxicity of prostate and breast cancer cells treated with these two copper complexes, supporting further investigation of potential use of these two new anticancer complexes for treatment of prostate and breast cancer metastasis.

AB - Copper complexes with strong anticancer activity are promising new drugs for treatment of patients with metastatic cancer. Copper 8-hydroxyquinoline-2-carboxaldehyde-thiosemicarbazide (CuHQTS) and copper 8-hydroxyquinoline-2-carboxaldehyde-4,4-dimethyl-3-thiosemicarbazide (CuHQDMTS) were found to have strong anticancer activity against cisplatin-resistant neuroblastoma cells and prostate cancer cells. This study aimed to synthesize and characterize two new anticancer copper complexes, copper complex of (4R)-(−)-2-Thioxo-4-thiazolidinecarboxylic acid (CuTTDC), and copper complex of 3-Rhodaninepropionic acid-copper complex (CuRDPA). Cell growth inhibition and cytotoxicity of CuTTDC and CuRDPA on prostate and breast cancer cells were evaluated with Cell Counting Kits-8 (CCK8) assay and fluorescent microscopic imaging respectively. Strong anticancer activity of CuTTDC and CuRDPA was demonstrated by growth inhibition and cytotoxicity of prostate and breast cancer cells treated with these two copper complexes, supporting further investigation of potential use of these two new anticancer complexes for treatment of prostate and breast cancer metastasis.

KW - (4R)-(-)-2-Thioxo-4-thiazolidinecarboxylic acid

KW - 3-Rhodaninepropionic acid

KW - Anticancer copper complex

KW - Breast cancer

KW - Fluorescent microscopic imaging

KW - Green fluorescence protein

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=85028972969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028972969&partnerID=8YFLogxK

U2 - 10.1007/s10895-017-2177-0

DO - 10.1007/s10895-017-2177-0

M3 - Article

C2 - 28889336

AN - SCOPUS:85028972969

SP - 1

EP - 8

JO - Journal of Fluorescence

JF - Journal of Fluorescence

SN - 1053-0509

ER -